Clinical & Radiological Evaluation of Acoustic Neuromas With Spontaneous

Clinical Trial Summary

To evaluate the regression characteristics of this Acoustic Neuroma population using volumetric data To study the relationship between regression and clinical characteristics including tinnitus, dizziness, hearing loss, and the intrinsic characteristics of the patients.

See also
Status	Clinical Trial	Phase
Not yet recruiting	`NCT04101409` - Impact of Shared Decision-Making With Decision Aids on Acoustic Neuroma Treatment Choice: A Randomized Controlled Trial	N/A
Completed	`NCT01129687` - Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy
Terminated	`NCT01345136` - Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma	Phase 2

See also

Status

Clinical Trial

Phase

Not yet recruiting

NCT04101409 - Impact of Shared Decision-Making With Decision Aids on Acoustic Neuroma Treatment Choice: A Randomized Controlled Trial

N/A

Completed

NCT01129687 - Subtotal Resection of Large Acoustic Neuromas With Possible Stereotactic Radiation Therapy

Terminated

NCT01345136 - Study of RAD001 for Treatment of NF2-related Vestibular Schwannoma

Phase 2

Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.

Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.

Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.

Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

NCT number	NCT03970681
Study type	Observational
Source	University Hospital, Strasbourg, France
Contact	Anne CHARPIOT, MD, PhD
Phone	33 3 88 12 76 49
Email	anne.charpiot@chru-strasbourg.fr
Status	Recruiting
Phase
Start date	May 29, 2019
Completion date	May 2020

Clinical and Radiological Evaluation of Acoustic Neuromas With Spontaneous Shrinkage

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms